[Experiences with HD-Ara C treatment in leukemia patients].
Experience with HD-Ara C in combination with AMSA was gained in 13 patients suffering from ANLL in various stages of their disease. They are incorporated in 3 large co-operative, mulicenter studies of the E.O.R.T.C. dealing with cyclic-alternating "maintenance", relapse patients and refractory ANLL.
D000208:Acute Disease; D000609:Aminoacridines / Q000008:administration & dosage; D000677:Amsacrine; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy
D000609:Aminoacridines; D000677:Amsacrine; D003561:Cytarabine
Erfahrungen mit der HD-Ara C Behandlung bei Leukämie-Patienten.